Morbidity | Control group (n = 20) | Milked group (n = 20) | 95% CI | p Value |
Polycythaemia | 0 (0) | 0 (0) | – | – |
RDS | 13 (75) | 14 (70) | 0.33 to 4.73 | 0.74 |
PDA | 7 (35) | 5 (25) | 0.15 to 2.43 | 0.49 |
Hyperkalaemia | 5 (25) | 3 (15) | 0.11 to 2.60 | 0.43 |
IVH | 5 (25) | 3 (15) | 0.11 to 2.60 | 0.43 |
IVH ⩾III | 4 (20) | 2 (10) | 0.07 to 2.76 | 0.38 |
Intestinal perforation | 2 (10) | 1 (5) | 0.04 to 5.68 | 0.56 |
(n = 17) | (n = 18) | |||
PVL | 2 (11.8) | 1 (5.6) | 0.04 to 5.37 | 0.52 |
CLD at 4 weeks | 4 (23.5) | 3 (16.7) | 0.12 to 3.46 | 0.61 |
CLD at 36 weeks | 4 (23.5) | 0 (0.0) | 0.01* | |
ROP ⩾2 | 10 (58.8) | 6 (33.3) | 0.09 to 1.39 | 0.14 |
ROP ⩾3 | 7 (41.2) | 2 (11.1) | 0.03 to 1.04 | 0.05 |
Data are No (%)
*p<0.05.
CLD, chronic lung disease; IVH, intraventricular haemorrhage; PDA, patent ductus arteriosus; PVL, periventricular leucomalacia; RDS, respiratory distress syndrome; ROP, retinopathy of prematurity.